World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys.

Autor:	Ekhtiari H; Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States.; Laureate Institute for Brain Research, Tulsa, OK, United States., Khojasteh Zonoozi A; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Rafei P; Trinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ireland., Abolghasemi FS; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Pemstein D; Political Science and Public Policy & Challey Institute, North Dakota State University, Fargo, ND, United States., Abdelgawad T; Faculty of Medicine, Cairo University, Cairo, Egypt., Achab S; Faculty of Medicine, Sociological and Psychological Research Unit, Department of Psychiatry, University of Geneva, Geneva, Switzerland., Ghafri HA; National Rehabilitation Center, Abu Dhabi, United Arab Emirates., Al'Absi M; Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States., Bisch M; Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France., Conti AA; Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom., Ambekar A; National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India., Arunogiri S; Monash Addiction Research Centre, Eastern Health Clinical School, Melbourne, VIC, Australia., Bhad R; National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India., Bilici R; Faculty of Medicine, Department of Psychology, Istanbul Ticaret University, Istanbul, Türkiye., Brady K; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States., Bunt G; School of Medicine, New York University, New York City, NY, United States., Busse A; Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC), Vienna, Austria., Butner JL; Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States., Danesh A; Division of Prevention Science, University of California, San Francisco, San Francisco, CA, United States., El-Khoury J; Lebanese Psychiatric Society, Beirut, Lebanon., Omari FE; Faculty of Medicine, University Mohammed Vth of Rabat, Rabat, Morocco., Jokūbonis D; Republican Center for Addictive Disorders, Lithuanian University of Health Sciences, Kaunas, Lithuania., de Jong C; Behavioral Science Institute, Radboud University, Nijmegen, Netherlands., Dom G; Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium., Ebrahimi M; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Fathi Jouzdani A; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Ferri M; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal., Galea-Singer S; DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom.; National Health Service (NHS) Fife Addiction Services, Cameron Hospital, Windygates, United Kingdom., Parker DG; School of Public Health, National University of Cordoba, Cordoba, Argentina., Higuchi S; National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan., Kathiresan P; Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Khelifa E; Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia., Kouimtsidis C; National Office for Addressing Drugs, Athens, Greece.; Surrey and Borders Partnership, National Health Service (NHS) Foundation Trust, Leatherhead, United Kingdom.; Department of Medicine, Imperial College London, London, United Kingdom., Krupitsky EM; Department of Addictions, Bekhterev National Medical Research Center for Psychiatry and Neurology, St. Petersburg, Russia., Long J; Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Maremmani I; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy.; UniCamillus, International Medical University in Rome, Rome, Italy., McGovern G; Irish Chapter of International Society of Addiction Medicine (IRE-ISAM), Dublin, Ireland., Mohaddes Ardabili H; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.; Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Rahimi-Movaghar A; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Rataemane ST; Department of Psychiatry, University of Limpopo, Polokwane, South Africa., Sangchooli A; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia., Sibeko G; Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa., Vella AM; Foundation for Social Welfare Services (FSWS), Sedqa, Santa Venera, Malta., Vista SBD; Department of Psychiatry and Behavioral Medicine, College of Medicine and Philippines General Hospital, University of the Philippines Manila, Manila, Philippines., Zare-Bidoky M; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Zhao M; Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China., Javed A; Pakistan Psychiatric Research Centre, Fountain House, Lahore, Pakistan., Potenza MN; Department of Psychiatry and Child Center, Yale School of Medicine, New Haven, CT, United States.; Connecticut Mental Health Center, New Haven, CT, United States.; Connecticut Council on Problem Gambling, Wethersfield, CT, United States.; Wu Tsai Institute and Department of Neuroscience, Yale University, New Haven, CT, United States., Baldacchino AM; DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom.
Jazyk:	angličtina
Zdroj:	Frontiers in psychiatry [Front Psychiatry] 2024 Mar 11; Vol. 15, pp. 1230318. Date of Electronic Publication: 2024 Mar 11 (Print Publication: 2024).
DOI:	10.3389/fpsyt.2024.1230318
Abstrakt:	Addiction medicine is a dynamic field that encompasses clinical practice and research in the context of societal, economic, and cultural factors at the local, national, regional, and global levels. This field has evolved profoundly during the past decades in terms of scopes and activities with the contribution of addiction medicine scientists and professionals globally. The dynamic nature of drug addiction at the global level has resulted in a crucial need for developing an international collaborative network of addiction societies, treatment programs and experts to monitor emerging national, regional, and global concerns. This protocol paper presents methodological details of running longitudinal surveys at national, regional, and global levels through the Global Expert Network of the International Society of Addiction Medicine (ISAM-GEN). The initial formation of the network with a recruitment phase and a round of snowball sampling provided 354 experts from 78 countries across the globe. In addition, 43 national/regional addiction societies/associations are also included in the database. The surveys will be developed by global experts in addiction medicine on treatment services, service coverage, co-occurring disorders, treatment standards and barriers, emerging addictions and/or dynamic changes in treatment needs worldwide. Survey participants in categories of (1) addiction societies/associations, (2) addiction treatment programs, (3) addiction experts/clinicians and (4) related stakeholders will respond to these global longitudinal surveys. The results will be analyzed and cross-examined with available data and peer-reviewed for publication. Competing Interests: 2.10.6All the investigators involved in designing the surveys, analyzing the data, interpreting the results and publishing the reports will need to report any potential conflict of interest in advance and inform the principal investigators if there is any update in their conflict of interest within 3 months.Dr. MP has consulted for Opiant Therapeutics, Game Day Data, Baria-Tek, the Addiction Policy Forum, AXA, and Idorsia Pharmaceuticals; been involved in a patent application with Yale University and Novartis; received research support from Mohegan Sun Casino, Children and Screens and the Connecticut Council on Problem Gambling; is on the Boards of multiple organizations including the International Society of Addiction Medicine and the Addiction Policy Forum; been a principal investigator on a grant supporting the annual conference of the International Society of Addiction Medicine; participated in surveys, mailings, or telephone consultations related to drug addictions, internet use, impulse-control disorders, and other health topics; consulted for or advised gambling, non-profit and legal entities on issues related to internet use, impulse-control and/addictive disorders; and given academic lectures in grand rounds, continuing medical education events, and other clinical or scientific venues. Dr. AMB has no conflicts of interest with regard to the current work. However unrelated to this project he has received unrestricted educational grants from Schering Plough, Merck Serono, Reckitt Benckiser, CAMURUS and Indivior. The remaining authors declare that the research was conducted in the absence of commercial or financial relationships constituting conflicts of interest. (Copyright © 2024 Ekhtiari, Khojasteh Zonoozi, Rafei, Abolghasemi, Pemstein, Abdelgawad, Achab, Ghafri, Al’Absi, Bisch, Conti, Ambekar, Arunogiri, Bhad, Bilici, Brady, Bunt, Busse, Butner, Danesh, El-Khoury, Omari, Jokūbonis, Jong, Dom, Ebrahimi, Fathi Jouzdani, Ferri, Galea-Singer, Parker, Higuchi, Kathiresan, Khelifa, Kouimtsidis, Krupitsky, Long, Maremmani, McGovern, Mohaddes Ardabili, Rahimi-Movaghar, Rataemane, Sangchooli, Sibeko, Vella, Vista, Zare-Bidoky, Zhao, Javed, Potenza and Baldacchino.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu